Start free
SignalUS

Drug shortage: Liraglutide Injection (SAXENDA, LIRAGLUTIDE, VICTOZA)

FDA lists 11 presentations as Current. Availability: Limited Availability (3), Available (6). Reason: Delay in shipping of the drug; Discontinuation of the manufacture of the drug. Companies: Novo Nordisk, Inc., Meitheal Pharmaceuticals, Inc., Hikma Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..

Published by source
2023-07-18
First seen by Reality Radar
2026-10-22
Last verified
2026-10-30

Affected

Manufacturer
Novo Nordisk, Inc.
Products
Liraglutide Injection SAXENDA LIRAGLUTIDE VICTOZA

Whether your exact unit is affected depends on the model, serial number and region in the official notice.

What the official notice says

Risk: Current — Limited Availability

Remedy / actions:

  • Product will be available until discontinuation in January 2027; Discontinuation of the manufacture of the drug
  • Estimated shortage duration: TBD

Is this affecting you?

Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.

Track it free

Sources

Evidence ledger

Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.

EntryKindObservedEvidence hashEntry hash
#903new2026-10-22b158195b99af…2351e4748f6514da15…9470a9
#1151update2026-10-237f4df0729f2f…7f279241e4edd9257a…2ef1e7
#1355update2026-10-239e54f1fa72e2…7093b91e463f7c3b58…baa8f7
#2174update2026-10-2748a0f378bd9c…1a7f322f5e57b20fbf…efeb93
#2415update2026-10-277b946f1173ca…ae6131449714297de2…0da7bc
#2549update2026-10-284f076f10df14…205ccca41fbed0c10a…c53249
#2713update2026-10-2872d0881d9afe…fd62a14294b8bd2d5e…808bcb
#2840update2026-10-296cd5209748e3…34915149d0aae41df6…ae6e37
#3087update2026-10-30277850dcfaaa…a60971948d983ec592…dd4d62
#3237update2026-10-30777163f1c12e…3693c20c25ef8add7b…3b4568

Chain head: #3332 f9027bc95d35…745b9e

Raw ledger entries (JSON) · Verify chain

Share this signal